American Oriental Bioengineering To Present at the UBS Global Life Sciences Conference

Monday, September 24, 2007 General News J E 4
NEW YORK, Sept. 24 American OrientalBioengineering, Inc. (NYSE: AOB), a leading manufacturer and distributor ofplant-based pharmaceutical and nutraceutical products in China, todayannounced that the Company will attend the UBS Global Life Sciences Conferenceon September 27, 2007 at The Grand Hyatt hotel in New York City. Managementis currently scheduled to present at 10:30 a.m. ET. Listeners may access alive webcast of the presentation by visiting the UBS conference webcast linkat

Investors who would like more information about attending the UBS GlobalLife Sciences Conference should contact their UBS sales representative.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering is a leading, fully integrated, plantbased pharmaceutical and plant based nutraceutical company dedicated toimproving health through the development, manufacture and commercialization ofmodernized plant based products in China.

Safe Harbor Statement

This news release contains forward-looking statements as defined by thePrivate Securities Litigation Reform Act of 1995. Forward-looking statementsinclude statements concerning plans, objectives, goals, strategies, futureevents or performance, and underlying assumptions and other statements thatare other than statements of historical facts. These statements are subject touncertainties and risks including, but not limited to, product and servicedemand and acceptance, changes in technology, economic conditions, the impactof competition and pricing, government regulation, and other risks containedin reports filed by the Company with the Securities and Exchange Commission.All such forward-looking statements, whether written or oral, and whether madeby or on behalf of the company, are expressly qualified by the cautionarystatements and any other cautionary statements which may accompany theforward-looking statements. In addition, the company disclaims any obligationto update any forward-looking statements to reflect events or circumstancesafter the date hereof.

SOURCE American Oriental Bioengineering, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Cardinal Health Names CEO R. Kerry Clark as Chairm...
European Union's CHMP Issues Positive Opinion on P...